Journals / Medicine Science / 2018 / Cilt: 7 - Sayı: 3

Mycobacterium / HIV interaction and development and emergence of unique Mycobacterium strains and the challenges they pose

Pages
720–723
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is essential to interrogate this assumption to generate information that may lead to improved to control of TB and NTM epidemics.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The upsurges of tuberculous (TB) and non-tuberculous mycobacterial (NTM) epidemics are believed to be associated with the Human Immunodeficiency virus (HIV) / acquired immunodeficiency syndrome (AIDS) pandemic.
📊
Key Findings & Data:Tuberculosis kills over 2 million people worldwide every year even though the disease is preventable and curable.
💡
Conclusion & Impact:It is essential to interrogate this assumption to generate information that may lead to improved to control of TB and NTM epidemics.
🔬Design:Review & Systematic Survey
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Özet

The upsurges of tuberculous (TB) and non-tuberculous mycobacterial (NTM) epidemics are believed to be associated with the Human Immunodeficiency virus (HIV) / acquired immunodeficiency syndrome (AIDS) pandemic. Tuberculosis kills over 2 million people worldwide every year even though the disease is preventable and curable. The World Health Organization (WHO) in 2005 declared TB as a public health emergency due its high morbidity and mortality worldwide. It is feared that people in the excess of one billion will contract TB with the attendant 35 million deaths from the disease by the year 2020. The majority of these will be HIV / AIDS patients. The TB - HIV co-infection problem is further aggravated by the emergence of NTM, which cause TB-like syndromes among immunocompromised patients. The association of HIV / AIDS with phenomena such as increasing of multiple drug resistant TB and the NTM syndromes may be pointing to the possibility of HIV - Mycobacterium genomic interaction resulting into the emergence of unique Mycobacterium strains. The objective of this article was to theorize the possibility of occurrence of Mycobacterium - HIV genomic interaction and emergence of unique Mycobacterium strains, and the opportunities such occurrence may provide in the world of medicine. Literature search on internet and peer reviewed articles in journals were reviewed to deduce the possibility of Mycobacterium and HIV genomic interaction and development of new and unique strains of Mycobacterium. The intimate association of the upsurge of TB and NTM epidemics with HIV / AIDS raises the assumption of occurrence of Mycobacterium - HIV genomic interaction in Mycobacterium - HIV co-infected individuals, which may lead to development of unique Mycobacterium strains. It is essential to interrogate this assumption to generate information that may lead to improved to control of TB and NTM epidemics.

🔖

Cite This Article

NYAMOGOBA, H. (2018). Mycobacterium / HIV interaction and development and emergence of unique Mycobacterium strains and the challenges they pose. Medicine Science, Cilt: 7 - Sayı: 3, 720–723. https://ajindex.com/articles/277273

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Mallory KF, Churchyard GJ, Kleinschmidt I, et al. The impact of HIV infection on recurrence of tuberculosis in south African gold miners. Int J Tuberc Lung Dis. 2000;4:455-62. United Nations and AIDS. Global Facts and Figures: The global AIDS epidemic. UNAIDS Geneva, Switzerland. 2009;7-21. UNAIS, 203 United Nations & AIDS (UNAIDS). Accelerating action against AIDS in Africa. Geneva, Switzerland, 2003.
  2. Johnson JL, Ellner JJ. Tuberculosis and atypical mycobacterial infections, In: Guerrrant RL, Walker DH and Weller PF, eds, Tropical Infectious Diseases: Principles, Pathogens & Practice, Vol. 1. Philadelphia: Churchill Livingstone. 1999;443-73.
  3. Griffith DE, Aksamit T, Brown-Elliot BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am. J. Respir. Crit Care Med. 2007;175:367-416. American Thoracic Society (ATS). An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. 2007. Buijtels PC, van der Sande MA, de Graaff CS, et al. Nontuberculous mycobacteria, Zambia. Emerg Infect Dis. 2009;15:242-9. WHO. Interim policy on collaborative TB/HIV activities. WHO/HTM/ TB/2005.355. Geneva. Nullis-Kapp, C. Africa is worst hit by dual epidemic. Bull World Health Organ. 2005;83:165-6.
  4. Kolattukudy PE, Fernandes ND, Aza AK, et al. Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria. Mol. Microbiol. 1997;24:263-70.
  5. Cole ST, Brosch R, Pakhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from complete genome sequence. Nature. 1998;393:537-44.
  6. Gurr MI, Harwood JL. Lipid in cellular structures. In: Lipid biochemistry. An introduction 4th edition, Chapman & Hall, London, 1991;281-8.
  7. Glickman MS, Cox JS, Jacobs WR Jr. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol cell. 2000;5:717-27. Pfyffer GE. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing. Schweiz Med Wochenscr. 2000;130:1909-13.
  8. Kourilsky P, Knapp A. Lysogenization by bacteriophage lambda. III. Multiplicity dependent phenomena occurring upon infection by lambda. Biochimie. 1974;56:1517-23.
  9. Chernushenko EF, Klimenko MT, Byalink IB. Discovery of changed Mycobacterium (L-forms) in TB patients. Int J Tuberc Lung Dis. 1997;1:S146. Poggio G, Togneri A, Reniero A. et al. AIDS-related multi-drug resistant tuberculosis “M” strain spreads with t